1.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00897, UCI 06-07, N01CN35160, CDR0000558657, UCIRVINE-UCI04-3-01, UCI04-3-01, UCIRVINE-UCI-HS-2006-4593, NCT00513461
|